BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12447707)

  • 1. Genetics in autoimmune hepatitis.
    Donaldson PT
    Semin Liver Dis; 2002 Nov; 22(4):353-64. PubMed ID: 12447707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela.
    Fortes Mdel P; Machado IV; Gil G; Fernández-Mestre M; Dagher L; León RV; Bianco NE; Tassinari P
    Liver Int; 2007 Dec; 27(10):1409-16. PubMed ID: 17927716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis.
    Czaja AJ
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):379-88. PubMed ID: 18328791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients.
    Djilali-Saiah I; Renous R; Caillat-Zucman S; Debray D; Alvarez F
    J Hepatol; 2004 Jun; 40(6):904-9. PubMed ID: 15158329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Liver Int; 2006 Dec; 26(10):1201-8. PubMed ID: 17105585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India.
    Shankarkumar U; Amarapurkar DN; Kankonkar S
    J Gastroenterol Hepatol; 2005 Feb; 20(2):193-7. PubMed ID: 15683420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.
    Bittencourt PL; Farias AQ; Porta G; Cançado EL; Miura I; Pugliese R; Kalil J; Goldberg AC; Carrilho FJ
    J Clin Gastroenterol; 2008 Mar; 42(3):300-5. PubMed ID: 18223493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas polymorphisms influence susceptibility to autoimmune hepatitis.
    Hiraide A; Imazeki F; Yokosuka O; Kanda T; Kojima H; Fukai K; Suzuki Y; Hata A; Saisho H
    Am J Gastroenterol; 2005 Jun; 100(6):1322-9. PubMed ID: 15929764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune hepatitis in Brazil: an overview.
    Goldberg AC; Bittencourt PL; Oliveira LC; Ramasawmy R; Marin ML; Palacios SA; Kalil J; Porta G
    Scand J Immunol; 2007; 66(2-3):208-16. PubMed ID: 17635798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.
    de Boer YS; van Gerven NM; Zwiers A; Verwer BJ; van Hoek B; van Erpecum KJ; Beuers U; van Buuren HR; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Kraal G; Mulder CJ; van Nieuwkerk CM; Fischer J; Berg T; Stickel F; Sarrazin C; Schramm C; Lohse AW; Weiler-Normann C; Lerch MM; Nauck M; Völzke H; Homuth G; Bloemena E; Verspaget HW; Kumar V; Zhernakova A; Wijmenga C; Franke L; Bouma G; ; ;
    Gastroenterology; 2014 Aug; 147(2):443-52.e5. PubMed ID: 24768677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule.
    Lim YS; Oh HB; Choi SE; Kwon OJ; Heo YS; Lee HC; Suh DJ
    J Hepatol; 2008 Jan; 48(1):133-9. PubMed ID: 18022727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis.
    Donaldson PT; Czaja AJ
    Clin Liver Dis; 2002 Aug; 6(3):707-25. PubMed ID: 12362576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between FCRL3 and FcgammaRII polymorphisms in Japanese type 1 autoimmune hepatitis.
    Umemura T; Ota M; Yoshizawa K; Katsuyama Y; Ichijo T; Tanaka E; Kawa S; Kiyosawa K
    Clin Immunol; 2007 Mar; 122(3):338-42. PubMed ID: 17020818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil.
    Bittencourt PL; Palácios SA; Cançado EL; Porta G; Carrilho FJ; Laudanna AA; Kalil J; Goldberg AC
    Am J Gastroenterol; 2003 Jul; 98(7):1616-20. PubMed ID: 12873588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HLA class II alleles and autoimmune hepatitis type 1 in Thai patients.
    Tanwandee T; Wanichapol S; Vejbaesya S; Chainuvati S; Chotiyaputta W
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S73-8. PubMed ID: 17722299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
    Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
    Schott E; Witt H; Pascu M; van Boemmel F; Weich V; Bergk A; Halangk J; Müller T; Puhl G; Wiedenmann B; Berg T
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):947-51. PubMed ID: 18049163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development.
    Lapierre P; Béland K; Djilali-Saiah I; Alvarez F
    J Autoimmun; 2006 Mar; 26(2):82-9. PubMed ID: 16380229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic developments in autoimmune thyroid disease: an evolutionary process.
    Zeitlin AA; Simmonds MJ; Gough SC
    Clin Endocrinol (Oxf); 2008 May; 68(5):671-82. PubMed ID: 18081880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune liver disease.
    Czaja AJ
    Curr Opin Gastroenterol; 2007 May; 23(3):255-62. PubMed ID: 17414840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.